Aguiar, Magda http://orcid.org/0000-0002-7966-6897
Harrison, Mark
Munro, Sarah
Burch, Tiasha
Kaal, K. Julia
Hudson, Marie
Bansback, Nick
Laba, Tracey-Lea
Funding for this research was provided by:
BC Support Unit (HESM-001)
Article History
First Online: 17 July 2020
Compliance with Ethical Standards
:
: The preparation of this article was possible through the financial support from the BC SUPPORT Unit Health Economics and Simulation Modelling Methods Cluster, which is part of British Columbia’s Academic Health Science Network (Award number: HESM-001). The BC SUPPORT Unit receives funding from the Canadian Institutes of Health Research and the Michael Smith Foundation for Health Research<i>.</i>
: Magda Aguiar is supported by a CIHR’s Health System Impact Postdoctoral Fellowship. Mark Harrison is supported by a Michael Smith Foundation for Health Research Scholar Award 2017 (#16813) and a Young Investigator Salary Award 2016 (until 2019) from The Arthritis Society (YIS-16-104). Mark Harrison held the UBC Professorship in Sustainable Health Care, which between 2014 and 2017 was funded by Amgen Canada, AstraZeneca Canada, Eli Lilly Canada, GlaxoSmithKline, Merck Canada, Novartis Pharmaceuticals Canada, Pfizer Canada, Boehringer Ingelheim (Canada), Hoffman-La Roche, LifeScan Canada and Lundbeck Canada. Sarah Munro is supported by a Michael Smith Foundation for Health Research Scholar Award in partnership with the Centre for Health Evaluation and Outcome Sciences 2019 (#18270). Tiasha Burch and Julia Kaal have no conflicts of interest that are directly relevant to the content of this article. Marie Hudson is funded by the Fonds de recherche du Québec-Santé. Nick Bansback is co-lead of the Health Economics and Simulation Modelling Methods cluster, part of the BC SUPPORT Unit that commissioned this work as part of their mandate to explore and develop new methods for patient-oriented research. Tracey-Lea Laba is supported by an NHMRC Early Career Postdoctoral fellowship (APP1110230).